Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies
A significant proportion of hematological malignancies remain limited in treatment options. Immune system modulation serves as a promising therapeutic approach to eliminate malignant cells. Cytotoxic T lymphocytes (CTLs) play a central role in antitumor immunity; unfortunately, nonspecific approache...
Saved in:
| Main Authors: | Baixin Ye, Creed M. Stary, Qingping Gao, Qiongyu Wang, Zhi Zeng, Zhihong Jian, Lijuan Gu, Xiaoxing Xiong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2017/5210459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01) -
Prospectives of T-cells genetic programming in adoptive immunotherapy of malignancies
by: O. L. Morozova, et al.
Published: (2016-09-01) -
PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. CANCERS AND HEMATOLOGICAL MALIGNANCIES
by: Article Editorial
Published: (2015-06-01) -
“A.B.C.” of Immunotherapy in Hematological Malignancies…Promise and Perils
by: Jyoti Bajpai, et al.
Published: (2024-04-01) -
PET/CT in the Evaluation of CAR-T Cell Immunotherapy in Hematological Malignancies
by: Shashi B. Singh MBBS, et al.
Published: (2024-05-01)